DiabetOmics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $16.6M

  • Investors
  • 7

DiabetOmics General Information

Description

Operator of a medical diagnostics company intended to offer point-of-care tests for early detection of diabetes and Latent Autoimmune Diabetes in adults. The company's technology measures total saliva glycosylated protein levels to estimate recent average blood glucose levels and also offers the pregnancy metabolic profile to estimate the risk of preeclampsia and gestational diabetes in expectant mothers, enabling professionals to access efficient technology for early diabetes detection.

Contact Information

Website
www.diabetomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2345 North East Overlook Drive
  • Suite Number 140
  • Hillsboro, OR 97006
  • United States
+1 (503)
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Vertical(s)
Digital Health, FemTech, HealthTech
Corporate Office
  • 2345 North East Overlook Drive
  • Suite Number 140
  • Hillsboro, OR 97006
  • United States
+1 (503)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiabetOmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 15-Jul-2020 $16.6M Completed Generating Revenue
5. Later Stage VC (Series D) 19-Jan-2018 Completed Generating Revenue
4. Later Stage VC (Series C1) 12-Mar-2015 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Oct-2014 Completed Generating Revenue
2. Grant 31-Jul-2013 $733K $4.2M Completed Generating Revenue
1. Early Stage VC (Series A) 11-Oct-2011 $4.2M $4.2M Completed Generating Revenue
To view DiabetOmics’s complete valuation and funding history, request access »

DiabetOmics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series E
Series D
Series C1
Series C
Series B 1,000,000 $9.39 $9.39 1x $9.39 10.23%
Series A 2,000,000 $2.5 $2.5 1x $2.5 20.45%
To view DiabetOmics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

DiabetOmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a medical diagnostics company intended to offer point-of-care tests for early detection of diabetes and Late
Diagnostic Equipment
Hillsboro, OR
24 As of 2023

London, United Kingdom
 

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DiabetOmics Competitors (18)

One of DiabetOmics’s 18 competitors is GlySure, a Formerly VC-backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySure Formerly VC-backed London, United Kingdom
Jana Care Venture Capital-Backed Watertown, MA
Microlife Private Equity-Backed Taipei, Taiwan
Nemaura Medical Corporation New York, NY
Omron Healthcare Formerly VC-backed Lake Forest, IL
You’re viewing 5 of 18 competitors. Get the full list »

DiabetOmics Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 27

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

DiabetOmics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4259818-A1 Systems and methods for rheumatoid arthritis biomarker detection Pending 10-Dec-2020
EP-4259818-A4 Systems and methods for rheumatoid arthritis biomarker detection Pending 10-Dec-2020
EP-3172572-A1 Biomarkers for assessment of preeclampsia Inactive 25-Jul-2014
US-20160025737-A1 Biomarkers for assessment of preeclampsia Inactive 25-Jul-2014
US-10996228-B2 Biomarkers for assessment of preeclampsia Active 25-Jul-2014 G01N33/6887
To view DiabetOmics’s complete patent history, request access »

DiabetOmics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DiabetOmics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
VenturEast Venture Capital Minority
Harrison School District 2 Corporation Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

DiabetOmics FAQs

  • When was DiabetOmics founded?

    DiabetOmics was founded in 2008.

  • Where is DiabetOmics headquartered?

    DiabetOmics is headquartered in Hillsboro, OR.

  • What is the size of DiabetOmics?

    DiabetOmics has 24 total employees.

  • What industry is DiabetOmics in?

    DiabetOmics’s primary industry is Diagnostic Equipment.

  • Is DiabetOmics a private or public company?

    DiabetOmics is a Private company.

  • What is the current valuation of DiabetOmics?

    The current valuation of DiabetOmics is .

  • What is DiabetOmics’s current revenue?

    The current revenue for DiabetOmics is .

  • How much funding has DiabetOmics raised over time?

    DiabetOmics has raised $77.8M.

  • Who are DiabetOmics’s investors?

    , VenturEast, Harrison School District 2, , and are 5 of 7 investors who have invested in DiabetOmics.

  • Who are DiabetOmics’s competitors?

    GlySure, Jana Care, Microlife, Nemaura Medical, and Omron Healthcare are some of the 18 competitors of DiabetOmics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »